Package Insert: Information for the User
Zolmitriptan Flas Combix 2.5 mg Bucodispersable Tablets EFG
Read this package insert carefully before starting to take this medication, as it contains important information for you.
- Keep this package insert, as you may need to refer to it again.
- If you have any questions, consult your doctor or pharmacist.
- This medication has been prescribed only for you and should not be given to others, even if they have the same symptoms as you, as it may harm them.
- If you experience any adverse effects, consult your doctor or pharmacist, even if they are not listed in this package insert. See section 4.
1. What is Zolmitriptan Flas Combix and how is it used
2. What you need to know before starting to take Zolmitriptan Flas Combix
3. How to take Zolmitriptan Flas Combix
4. Possible adverse effects
5. Storage of Zolmitriptan Flas Combix
6. Contents of the package and additional information
Zolmitriptán Flas Combix contains zolmitriptan and belongs to a group of medications called triptans.
Zolmitriptán Flas Combix is used to treat migraine headaches.
Do not take Zolmitriptán Flas Combix
If you are unsure whether any of this applies to you, consult your doctor or pharmacist.
Warnings and precautions
Consult your doctor or pharmacist before starting to takeZolmitriptán Flas Combix:
If you go to a hospital, inform the medical staff that you are taking Zolmitriptán Flas Combix.
Zolmitriptán Flas Combix is not recommended for people under 18 years or over 65.
Like other migraine treatments, excessive use of zolmitriptán may cause daily headaches or worsening of your migraine headaches. Consult your doctor if you think this is the case. You may need to stop using zolmitriptán to correct the problem.
Taking Zolmitriptán Flas Combix with other medications
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication. This includes herbal remedies and medications you purchase without a prescription.
Especially, inform your doctor if you are taking any of the following medications:
Migraine medications
Depression medications
Other medications
If you are using herbal preparations that contain St. John's Wort (Hypericum perforatum), it may be more likely that zolmitriptán side effects will occur.
Taking Zolmitriptán Flas Combix with food and drinks
You can take Zolmitriptán Flas Combix with or without food. This does not affect how Zolmitriptán Flas Combix works.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, or if you think you may be pregnant, consult your doctor or pharmacist before using this medication.
The effects of taking zolmitriptán during pregnancy are unknown. Before taking Zolmitriptán Flas Combix, inform your doctor if you are pregnant or trying to become pregnant.
Avoid breastfeeding within 24 hours after taking Zolmitriptán Flas Combix.
Driving and operating machinery
During a migraine crisis, your reactions may be slower than usual. Take this into account when driving or operating tools or machinery.
It is unlikely that zolmitriptán will affect driving or operating tools or machinery. However, it is best to wait and see how zolmitriptán affects you before attempting these activities.
This medication, like migraine, can cause drowsiness. If you experience these effects, avoid driving or operating machinery as it may be hazardous.
Zolmitriptán Flas Combix contains aspartamo.This medication may be harmful to people with phenylketonuria because it contains aspartamo, which is a source of phenylalanine.
Follow exactly the administration instructions for this medication as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
You can take Zolmitriptán Flas Combix as soon as a migraine headache begins. You can also take it once a headache has started.
If these tablets do not provide sufficient relief for your migraine, inform your doctor. Your doctor may increase the dose to 5 mg (two tablets of 2.5 mg) or change your treatment.
Do not take more than the prescribed dose.
If you take more Zolmitriptán Flas Combix than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91 562 04 20 indicating the medication and the amount ingested.
If you forgot to take Zolmitriptán Flas Combix
Do not take a double dose to make up for the missed doses.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications,Zolmitriptán Flas Combixcan produce adverse effects, although not everyone will experience them. Some of the symptoms listed below may be part of the migraine crisis itself.
Frequent Adverse Effects (may affect up to 1 in 10 people):
Less Frequent Adverse Effects (may affect up to 1 in 100 people):
Rare Adverse Effects (may affect up to 1 in 1,000 people):
Very Rare Adverse Effects (may affect up to 1 in 10,000 people):
If you experience adverse effects, consult your doctor or pharmacist even if they are not listed in this prospectus.
Keep this medication out of the sight and reach of children.
Do not store at a temperature above 30°C.
Do not usethis medicationafter the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medicines should not be disposed of through drains or in the trash. Dispose of the packaging and medicines you no longer need at the SIGRE collection pointof the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. By doing so, you will help protect the environment.
Composition ofZolmitriptán Flas Combix
- The active ingredient is zolmitriptan. Each buccal dispersible tablet contains 2.5 mg of zolmitriptan.
- The other components are: potassium polacrilin, anhydrous citric acid (E330), gelatin, microcrystalline cellulose (E460i), anhydrous colloidal silica, aspartame (E951), orange powder flavor, mannitol (E421), magnesium stearate (E470b), and sodium stearyl fumarate.
Appearance of the product and contents of the packaging
Round, speckled, white to cream-colored, smooth on both sides buccal dispersible tablets.
OPA/Al/PVC/Al blisters.
Blister packs containing 6 buccal dispersible tablets.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization
Combix Laboratories, S.L.U.
C/ Badajoz 2, Building 2
28223 Pozuelo de Alarcón (Madrid)
Spain
Responsible for manufacturing
Zydus France
ZAC Les Hautes Patures
Parc d'activités des Peupliers
25 Rue des Peupliers
92000 Nanterre
France
or
Centre Specialites Pharmaceutiques
Zac Du Suzot
35 Rue De La Chapelle
63450 Saint Amant Tallende
France
Last review date of this leaflet January 2013.
The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.